Peer Review reports
From: Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?
|1 Nov 2016||Submitted||Original manuscript|
|23 Nov 2016||Reviewed||Reviewer Report - Brian Allen|
|27 Nov 2016||Reviewed||Reviewer Report - Nicholas Rudnick|
|22 Dec 2016||Author responded||Author comments - Shi-Ting Feng|
|Resubmission - Version 2|
|22 Dec 2016||Submitted||Manuscript version 2|
|14 Feb 2017||Author responded||Author comments - Shi-Ting Feng|
|Resubmission - Version 3|
|14 Feb 2017||Submitted||Manuscript version 3|
|21 Feb 2017||Editorially accepted|
|23 Feb 2017||Article published||10.1186/s12885-017-3150-7|
You can find further information about peer review here.